Showing results (1821-1830 of 2,791) with videos related to
Sort By:
Pageof 280
Cytotherapy|September 15, 2022
A risk-based approach for cell line development, manufacturing and characterization of genetically engineered, induced pluripotent stem cell-derived allogeneic cell therapiesJennifer L Dashnau, Qiong Xue, Monica Nelson, et al.Cytotherapy|September 18, 2022
Subacute traumatic spinal cord injury: a systematic review and network meta-analysis of therapeutic strategies based on bone marrow mesenchymal stromal cells in animal modelsZhizhong Shang, Mingchuan Wang, Baolin Zhang, et al.Cytotherapy|December 3, 2023
Human CD4+CD25+ T cells expressing a chimeric antigen receptor against aberrant superoxide dismutase 1 trigger antigen-specific immunomodulationDavid J Graber, W James Cook, Marie-Louise Sentman, et al.Cytotherapy|December 30, 2023
Interleukin-37 contributes to endometrial regenerative cell-mediated immunotherapeutic effect on chronic allograft vasculopathyYafei Qin, Bo Shao, Shao-Hua Ren, et al.Cytotherapy|December 27, 2023
Incipient clonal hematopoiesis is accelerated following CD30.CAR-T therapyChiraag D Kapadia, Gerardo Rosas, Sachin G Thakkar, et al.Cytotherapy|December 15, 2023
Phospholipid scramblase 1 is involved in immunogenic cell death and contributes to dendritic cell-based vaccine efficiency to elicit antitumor immune response in vitroBarbara Montico, Annunziata Nigro, Maria Julia Lamberti, et al.Cytotherapy|March 14, 2024
Clinical-grade human embryonic stem cell-derived mesenchymal stromal cells ameliorate diabetic retinopathy in db/db miceLiyuan Rong, Wumei Wei, Yifan Fang, et al.Cytotherapy|March 11, 2024
Alternative target recognition elements for chimeric antigen receptor (CAR) T cells: beyond standard antibody fragmentsMatthew A Nix, Arun P WiitaCytotherapy|December 9, 2023
Influence of the isolation method on characteristics and functional activity of mesenchymal stromal cell-derived extracellular vesiclesRicardo Malvicini, Giada De Lazzari, Anna Maria Tolomeo, et al.Cytotherapy|November 6, 2023
Predicting the CD34 content of mobilized peripheral blood leukapheresis products: single institution experience over 20 yearsYaşa G Mutlu, Joan Sevcik, Joseph E Kiss, et al.Pageof 280